Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.720
-0.030 (-1.09%)
At close: Oct 8, 2025, 4:00 PM EDT
2.821
+0.101 (3.71%)
After-hours: Oct 8, 2025, 7:52 PM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $19.14 million as of October 8, 2025. Its market cap has increased by 31.11% in one year.
Market Cap
19.14M
Enterprise Value
7.20M
1-Year Change
31.11%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since November 5, 2015, Edesa Biotech's market cap has decreased from $74.90M to $19.14M, a decrease of -74.44%. That is a compound annual growth rate of -12.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 19.40M | 234.48% |
| Dec 31, 2024 | 5.80M | -60.00% |
| Dec 29, 2023 | 14.50M | -65.31% |
| Dec 30, 2022 | 41.80M | -45.07% |
| Dec 31, 2021 | 76.10M | 70.25% |
| Dec 31, 2020 | 44.70M | 45.13% |
| Dec 31, 2019 | 30.80M | 528.57% |
| Dec 31, 2018 | 4.90M | -42.35% |
| Dec 29, 2017 | 8.50M | -58.74% |
| Dec 30, 2016 | 20.60M | -62.34% |
| Dec 31, 2015 | 54.70M | -26.97% |
| Nov 5, 2015 | 74.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |